Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa.
Larrey
D
D
Marcellin
P
P
Fréneaux
E
E
Pessayre
D
D
Benhamou
J P
JP
D000328:Adult; D006526:Hepatitis C / Q000628:therapy; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D009103:Multiple Sclerosis / Q000503:physiopathology*; D011994:Recombinant Proteins
D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins